Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Bravo-Perez C, Sola M, Teruel-Montoya R, Garcia-Malo MD, Ortuno FJ, Vicente V, de Arriba F, Jerez A. Minimal Residual Disease in Multiple Myeloma: Something Old, Something New. Cancers (Basel). 2021 Aug 27;13(17):4332. doi: 10.3390/cancers13174332. PubMed PMID: 34503142; PubMed Central PMCID: PMC8430644.
AÑO: 2021; IF: 6.575
34503142
Bastos Oreiro M, Martin R, Gomez P, Lopez Munoz N, Rodriguez A, Liebana M, Navarro B, Sanchez-Gonzalez B, Mari P, Perez de Oteiza J, Gutierrez A, Bento L, Domingo Domenech E, Vidal MJ, Del Campo R, Perez Ceballos E, Infante M, Roldan A, Garcia Belmonte D, Santero M, Sureda A, Sanz RG, On Behalf Of The Geltamo Group. SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment. Cancers (Basel). 2021 May 17;13(10):2412. doi: 10.3390/cancers13102412. PubMed PMID: 34067616; PubMed Central PMCID: PMC8156414.
AÑO: 2021; IF: 6.575
34067616
Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo CM, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta AJ, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta MA, Pinana JL, Navarro D; Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH). Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment. Bone Marrow Transplant. 2021 Jun;56(6):1281-1290. doi: 10.1038/s41409-020-01157-x. Epub 2020 Dec 15. PubMed PMID: 33319853.
AÑO: 2021; IF: 5.174
33319853
Ding WY, Rivera-Caravaca JM, Marin F, Torp-Pedersen C, Roldan V, Lip GYH. Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS. J Clin Med. 2021 Jul 29;10(15):3357. doi: 10.3390/jcm10153357. PubMed PMID: 34362143; PubMed Central PMCID: PMC8348193.
AÑO: 2021; IF: 4.964
34362143
Bastida JM, Gonzalez-Porras JR, Rivera J, Lozano ML. Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia. Int J Mol Sci. 2021 Apr 21;22(9):4330. doi: 10.3390/ijms22094330. PubMed PMID: 33919295; PubMed Central PMCID: PMC8122256.
AÑO: 2021; IF: 6.208
33919295
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL